Varivax is a vaccine used to protect against chickenpox (varicella), a common viral infection that causes an itchy rash and fever. While often mild in children, chickenpox can be more severe in adults and may lead to complications.
The vaccine is recommended for children and adults who have not previously had chickenpox or been vaccinated, including those needing protection for work, travel, or household contact with vulnerable individuals.
Vaccination course
-
2-dose course
-
Dose 1: Day 0
-
Dose 2: 4–8 weeks after dose 1
Both doses are required to complete the course and provide full protection.
Booster doses
-
No routine booster is currently recommended after completing the 2-dose course
